Veracyte, Inc. (HDX)
HDX
Veracyte, Inc. acquired HalioDx in August 2021 and is involved in WP2 (COLOSSUS Biorepository & Histopathology Analyses) and in WP7 where a customized Next Generation Sequencing (NGS) companion diagnostic test will be developed. COLOSSUS classifiers will be translated into a targeted NGS assay that will enable fast and efficient determination of the COLOSSUS clusters.
Partner Details
Veracyte EU Headquarters (HDX)
Luminy Biotech Entreprises
163 Avenue De Luminy
13288 Marseille, Cedex 9
FRANCE

Dr Fabienne Hermitte

Dr Florence Monville
